paroxetine has been researched along with Diabetic Neuropathies in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, H; Ikeda, T; Ishida, Y; Nakamura, T; Naono, R; Nishimori, T; Takeda, R | 1 |
| Bach, FW; Gram, LF; Sindrup, SH | 1 |
| Brøsen, K; Gram, LF; Sindrup, SH | 1 |
| Beck-Nielsen, H; Gram, LF; Grodum, E; Sindrup, SH | 1 |
| Brøsen, K; Eshøj, O; Gram, LF; Mogensen, EF; Sindrup, SH | 1 |
2 trial(s) available for paroxetine and Diabetic Neuropathies
| Article | Year |
|---|---|
Plasma beta-endorphin is not affected by treatment with imipramine or paroxetine in patients with diabetic neuropathy symptoms.
Topics: Adult; Aged; Antidepressive Agents; beta-Endorphin; Diabetic Neuropathies; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Paroxetine; Piperidines | 1992 |
The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms.
Topics: Depression; Desipramine; Diabetic Neuropathies; Humans; Imipramine; Nervous System; Osmolar Concentration; Paroxetine; Piperidines; Serotonin Antagonists; Time Factors | 1990 |
3 other study(ies) available for paroxetine and Diabetic Neuropathies
| Article | Year |
|---|---|
Effects of intrathecal administration of newer antidepressants on mechanical allodynia in rat models of neuropathic pain.
Topics: Analgesics; Animals; Antidepressive Agents; Cyclopropanes; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Fluvoxamine; Hyperalgesia; Injections, Spinal; Male; Milnacipran; Pain Threshold; Paroxetine; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Sciatic Neuropathy; Selective Serotonin Reuptake Inhibitors; Serotonin; Spinal Cord | 2009 |
Pharmacokinetics of the selective serotonin reuptake inhibitor paroxetine: nonlinearity and relation to the sparteine oxidation polymorphism.
Topics: Adult; Aged; Diabetic Neuropathies; Female; Humans; Male; Middle Aged; Oxidation-Reduction; Paroxetine; Phenotype; Piperidines; Polymorphism, Genetic; Serotonin Antagonists; Sparteine | 1992 |
Concentration-response relationship in paroxetine treatment of diabetic neuropathy symptoms: a patient-blinded dose-escalation study.
Topics: Adult; Aged; Diabetic Neuropathies; Dosage Forms; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Pain Measurement; Paroxetine; Piperidines; Serotonin Antagonists | 1991 |